Please assess the completion status of the following clinical trial:

Trial Title: A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 19\~50 years old, healthy male volunteers~* \>55Kg(Body weight) and 18.5\<BMI\<28~Exclusion Criteria:~* AST or ALT \> 3 \* Upper normal range (Lab)~* Total bilirubin \> 2.0 mg/dl~* Systolic BP \>140 OR \<90, Diastolic BP \>100 OR \<60

- Gender: MALE
- Minimum Age: 19 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- YHD1119 (Type: EXPERIMENTAL): Pregabalin 300mg
- Lyrica (Type: ACTIVE_COMPARATOR): Pregabalin 150mg

Based on this trial design, predict the completion outcome and termination type (if applicable).